Brian Scanlan, Managing Partner
Brian Scanlan has amassed more than 25 years of senior business, sales and strategic advisory executive management experience within the pharmaceutical services industry from startups through large, multinational corporations. With more than two decades of experience leading aggressive top and bottom line performance improvements, Scanlan has established himself as a leader in driving organic/inorganic growth in the pharma services sector including active pharmaceutical ingredient (API) development & manufacturing, proprietary technologies, solid state & analytical chemistry, formulation development, process chromatography, from early preclinical development to commercial production and global launch. As a senior corporate executive, sales turnaround specialist and interim executive/advisor assessing and overcoming business and leadership obstacles, Scanlan has developed a consistent success record in delivering rapid, high-impact results and establishing a refined, defendable strategy for future growth.
As Founder & Managing Partner of Freedom Bioscience Partners, he leads management consulting services engagements providing a full range of service offerings and capabilities to pharmaceutical services companies (CROs/CMOs), technology companies, private equity firms, and investment banks. Developing customized solutions for clients, Scanlan serves in senior business advisory, interim executive and board advisory roles developing tactical and strategic solutions focused on revenue generation, enterprise value creation through mergers, acquisitions, joint ventures and leveraging intellectual property. With experience leading several corporate recapitalizations, including private equity transactions, mergers, acquisitions and alliances, he manages engagements driving enterprise value creation in preparation for sale, as well as diligence, acquisition target assessments, competitor/market analyses, asset/technology assessments, optimizing valuations. Supporting both immediate and long-term, sustained growth, Scanlan also leads engagements to drive top line growth, such as sales/marketing strategy, territory optimization, training, complimentary service alliances, global market strategy, indirect channel management, product commercialization and legislative & industry advocacy.
Prior to launching Freedom Bioscience Partners, L.L.C., he served as Chief Executive Officer/President, Chief Business Officer and Vice President of Corporate Development for Cambridge Major Laboratories, the leading global chemistry outsourcing provider of integrated drug development and manufacturing services to the pharmaceutical and biotechnology industries. During this time period, Scanlan led/co-led three recapitalizations, company re-branding, multiple innovative technology/sales partnerships and international sales capability expansions, which drove double digit revenue and EBITDA percentage growth annually for eight consecutive years.
Prior to joining CML, Scanlan managed business development and technology marketing for Rhodia Chirex, a multinational pharmaceutical technology, development and manufacturing firm focused on API’s. Bringing an energy to the business development organization, and combining his technical background, Scanlan was a top revenue producer in the US, while concurrently leading the marketing of the company’s technology portfolio. A trained Research Chemist, Scanlan began his career with UOP; within four years, he progressed to a marketing role providing planning, marketing and sales strategies for UOP’s Specialty Chemical group. During this time period, he was instrumental in securing a joint venture opportunity to leverage new technologies in GMP manufacturing environment facilitating the creation of Universal Pharma Technologies, LLC. As a member of the initial startup team for Universal Pharma, he built the global sales and marketing plan to position the company as a premiere innovator, developer and supplier of pharmaceutical manufacturing equipment and technologies to accelerate drug development.
In addition to his executive and sales leadership experience, Scanlan has also served on various industry and community boards and task forces, including serving on the Board of Governors and Bulk Pharmaceutical Task Force with the Society of Chemical Manufacturers & Affiliates (SOCMA), Founder of SE WI BioNet, Board of Directors with BioForward and Board of Trustees with The Leukemia & Lymphoma Society. He has also served as a Guest Lecturer at Rutgers University.
Scanlan received his Master of Business Administration degree from the Illinois Institute of Technology in Chicago and a Bachelor’s degree in Chemistry from Northern Illinois University.